Crealta to acquire Savient assets

Crealta Pharmaceuticals LLC (Lake Forest, Ill.) will acquire the pharmaceutical portfolio of Savient Pharmaceuticals Inc. (OTCQB:SVNTQ), including gout drug Krystexxa pegloticase, for about $120.4 mil...